Controlling and conquering incurable metastatic cancer by targeting the major tumor-driving K-RAS/SIAH pathway activation to stratify patients, identify resistant tumor clones, quantify therapy efficacy, forecast tumor relapse, and predict patient survival in the neoadjuvant settings Meeting Abstract

author list

  • Tang, A. H.; Lee, M. P.; Lee, C. D.; Lagever, A. C.; Van Reesema, Siewertsz L. L.; Collier, A. L.; Iyer, A. S.; Van Sciver, R. E.; Svyatova, E.; Kanda, K. F.; Winston, J. S.; Allen, C. A.; Chang, D. Z.; Petersen, G. M.; Hoefer, R. A.

publication date

  • April 1, 2019


published in


start page

  • 146

end page

  • 147


  • 36


  • 2